SCHEMBL7540310

SCHEMBL7540310

Cc1cncn1-c1ccc(NC=O)cc1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47
PTK2 Q05397 1/20 0.43
MAOA P21397 1/20 0.37
MAOB P27338 1/20 0.37
ALDH1A1 P00352 2/20 0.37
LMNA P02545 1/20 0.36
CSF1R P07333 1/20 0.34
RAB9A P51151 3/20 0.34
NPC1 O15118 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
LIMK1 P53667 1/20 0.32
FLT3 P36888 1/20 0.32
HSP90AA1 P07900 1/20 0.30
HSP90AB1 P08238 1/20 0.30
QPCT Q16769 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18500656 0.72 CYP3A4 (0.54) CYP3A4CYP2D6CYP2C9PTK2MAOA
SCHEMBL3272205 0.71 CYP3A4 (0.53) CYP3A4CYP2D6CYP2C9MAOAMAOB
SCHEMBL20627766 0.70 NPC1 (0.41) ALDH1A1LMNARAB9ANPC1SMN1; SMN2
SCHEMBL25442765 0.69 CYP3A4 (0.59) CYP3A4CYP2D6CYP2C9PTK2MAOA
SCHEMBL25442241 0.69 CYP3A4 (0.51) CYP3A4CYP2D6CYP2C9PTK2MAOA
SCHEMBL22478364 0.68 LMNA (0.45) CYP2D6CYP2C9PTK2ALDH1A1LMNA
SCHEMBL8391282 0.68 LMNA (0.55) CYP3A4CYP2D6LMNAMEN1KMT2A
SCHEMBL26662266 0.68 MAOA (0.43) CYP3A4CYP2D6CYP2C9PTK2MAOA
SCHEMBL10134015 0.68 MKNK1 (0.56) PTK2ALDH1A1LIMK1
SCHEMBL469386 0.67 ALDH1A1 (0.72) ALDH1A1LMNARAB9ANPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1999032454-A9 NITROGEN CONTAINING HETEROAROMATICS WITH ORTHO-SUBSTITUTED P1'S AS FACTOR XA INHIBITORS DU PONT PHARM CO (US) 2001-05-31 WO disclosed